心力衰竭与癌症的关联:背景证据与研究展望
近期流行病学分析提示,既往心力衰竭患者中新发癌症可能比无心力衰竭者更常见,但反对观点认为这源于两种高患病疾病的共现及更密集医学观察带来的检出增加。然而,生物学数据支持心力衰竭是一种致癌状态的假说,神经激素激活与肿瘤发生、进展和播散相关;低度炎症介导的系统性环境紊乱可能同时导致心力衰竭和恶性肿瘤。动物模型显示缺血后心力衰竭可促进肿瘤生长,探索心衰与恶性肿瘤的潜在通路是新的研究领域。
要点
- 心衰患者新发癌症可能更常见,但需排除共病与监测偏倚。
- 神经激素激活和低度炎症可能连接心衰与肿瘤发生。
- 缺血后心衰在动物模型中可促进肿瘤生长。
核心结论
- 心力衰竭可能与癌症风险增加相关,但因果关系尚待前瞻性研究验证。
研究设计与样本
- 本文为综述,基于近期流行病学分析与生物学证据探讨心衰与癌症的关联。
主要发现
- 流行病学分析提示既往心衰患者中新发癌症可能比无心衰者更常见。
- 反对观点包括两种高患病疾病的共现及心衰患者因密集医学观察导致肿瘤检出增加。
- 生物学数据支持心衰为致癌状态,神经激素激活与肿瘤发生、进展和播散相关。
- 低度炎症主导的系统性环境紊乱可能同时导致心衰和恶性肿瘤。
- 动物模型显示缺血后心衰可促进肿瘤生长。
局限性
- 支持心衰致癌的生物学数据多来自非专门针对心衰的研究,需重新评估。
- 流行病学观察可能受共病和监测偏倚影响,因果关系未明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent epidemiological analyses suggest that incident cancer may be more common among patients with preexisting heart failure (HF) than in patients without HF. Arguments against this notion have been the increased chance of co-occurrence of 2 high-prevalence conditions and increased tumor detection in patients with HF because of intensified medical observation. However, biological data lend support to the hypothesis that HF is an oncogenic condition. Neurohormonal activation has been related to cancer initiation, progression, and dissemination by studies not specifically focusing on HF, which are now reappraised in the light of the emerging evidence that tumors are diagnosed more often in HF than control cohorts. Furthermore, a thought-provoking scenario to be considered is that a systemically perturbed milieu, where low-grade inflammation plays a primary role, leads to both HF and malignancy, thus connecting 1 disease to another. Postischemic HF has been shown to promote tumor growth in an animal model. Exploring these and other pathways potentially linking HF to malignancy is a new and exciting field of research, with the ultimate goal of answering the question of whether HF does promote cancer.
引用
- Bertero E, Canepa M, Maack C, et al. Linking Heart Failure to Cancer: Background Evidence and Research Perspectives. Circulation. 2018. PMID: 30359132. doi:10.1161/CIRCULATIONAHA.118.033603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。